Michael Scolaro

Michael Scolaro

Sep 20, 2017

Group 6 Copy 717
-1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Developing a low-cost, rapid diagnostic for urogenital Schistosomiasis infection

We are developing a frugal diagnostic for urogenital schistosomiasis, a neglected tropical disease that...

Working towards a low-cost ostomy bag that doesn't leak

Ostomy bags are a daily medical necessity for 15 million people globally. However, these bags often delaminate...

How do chemical exposures trigger autoimmune diseases?

The cause of onset of autoimmune disease is poorly understood, but may be linked to exposure to certain...

Backer Badge Funded